Ionis Pharmaceuticals, Inc.
MODIFIED CRISPR RNA AND USES THEREOF

Abstract:

The present disclosure provides compounds comprising modified oligonucleotides for use in CRISPR. In certain embodiments, such modified oligonucleotides provide improved properties of crRNA.